Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Precision Bio Sciences Appoints Cindy Atwell As Chief Development and Business Officer and Cassie Gorsuch, Ph D As Chief Scientific Officer

PUBLIC · DTILJan 29, 2025•over 1 year ago

Position

Chief Scientific Officer

Company

Precision BioSciences

Cassie Gorsuch

DurhamBiotechnologyHealth CareGeneticsTherapeutics

Description

Precision BioSciences announced the appointment of Cindy Atwell as Chief Development and Business Officer, where she will oversee all development functions including clinical, translational, regulatory, and business development. Additionally, Cassie Gorsuch, PhD has been promoted to Chief Scientific Officer, responsible for non-clinical development and gene therapy discovery.

Company Information

Company

Precision BioSciences

Location

302 EAST PETTIGREW STREET

Durham, North Carolina, United States

About

Precision is a clinical stage gene editing company dedicated to improving life (DTIL) with its novel and proprietary ARCUS® genome editing platform that differs from other technologies in the way it cuts, its smaller size, and its simpler structure. Key capabilities and differentiating characteristics may enable ARCUS nucleases to drive more intended, defined therapeutic outcomes. Using ARCUS, Precision’s pipeline is comprised of in vivo gene editing candidates designed to deliver lasting cures for the broadest range of genetic and infectious diseases where no adequate treatments exist.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for Precision BioSciences's next move

Learn about Strategic plan

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months